Fig. 4From: The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancerTUNEL staining (green) of tumor and organs of control (A, D, G, J, M, P), single dose (B, E, H, K, N, R, Q) and fractionated dose group (C, F, I, L, O, R). Nuclei were counterstained with DAPI (blue). The staining solution without enzyme served as negative control (S–U). Scale bar: 100 µmBack to article page